Literature DB >> 26807175

The anti-apoptosis effect of MLAA-34 in leukemia and the β-catenin/T cell factor 4 protein pathway.

Lu Qian1, Wanggang Zhang2, Pengyu Zhang2, Bo Lei2, Xiu Wang3, Man Wang4, Ju Bai2, Aili He2.   

Abstract

Objective This study aims to observe the effects of MLAA-34 gene in leukemia and explore its mechanism. Methods MLAA-34 RNAi vector was constructed. NOD/SCID mice and 293T cells, K562 cells, HL60 cells and U937 cells were used in this study. They were divided into MLAA-34-siRNA group and control group. The proliferation ability and apoptosis of cells were detected. The expression levels of β-Catenin and TCF 4 were determined using western blotting and immunohistochemical methods. Results There was significant correlation between MLAA-34 gene and U937 cell proliferation, the apoptosis rates of U937 cells with siRNA infection were higher than that of control group. There were significant differences in the expression levels of β-Catenin and TCF 4 between U937 cells and U937 with MLAA-34-siRNA cells group. Conclusions MLAA-34 gene had anti-apoptotic effect in leukemia, which maybe through the β-Catenin/TCF 4 pathway.

Entities:  

Keywords:  MLAA-34; apoptosis; leukemia; β-Catenin/TCF 4 pathway

Year:  2015        PMID: 26807175      PMCID: PMC4697707     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

Review 1.  The promise and perils of Wnt signaling through beta-catenin.

Authors:  Randall T Moon; Bruce Bowerman; Michael Boutros; Norbert Perrimon
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 2.  The many ways of Wnt in cancer.

Authors:  Paul Polakis
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

Review 3.  Acute myeloid leukemia: epidemiology and etiology.

Authors:  Barbara Deschler; Michael Lübbert
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

Review 4.  Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.

Authors:  Jochen Greiner; Hartmut Döhner; Michael Schmitt
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

5.  Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.

Authors:  N Niitsu; Y Yamamoto-Yamaguchi; T Kasukabe; J Okabe-Kado; M Umeda; Y Honma
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

6.  Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia.

Authors:  Jianqiang Zhao; Aili He; Wanggang Zhang; Xin Meng; Liufang Gu
Journal:  Cancer Immunol Immunother       Date:  2011-01-15       Impact factor: 6.968

Review 7.  Acute myeloid leukaemia.

Authors:  Elihu Estey; Hartmut Döhner
Journal:  Lancet       Date:  2006-11-25       Impact factor: 79.321

Review 8.  The role of LEF/TCF factors in neoplastic transformation.

Authors:  Amod Ravindranath; Angeline O'Connell; Patrick G Johnston; Mohamed K El-Tanani
Journal:  Curr Mol Med       Date:  2008-02       Impact factor: 2.222

9.  Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

Authors:  Markus Schaich; Richard F Schlenk; Haifa K Al-Ali; Hartmut Döhner; Arnold Ganser; Gerhard Heil; Thomas Illmer; Rainer Krahl; Jürgen Krauter; Cristina Sauerland; Thomas Büchner; Gerhard Ehninger
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  4 in total

1.  Bioinformatic prediction and functional characterization of human KIAA0100 gene.

Authors:  He Cui; Xi Lan; Shemin Lu; Fujun Zhang; Wanggang Zhang
Journal:  J Pharm Anal       Date:  2016-11-02

2.  Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology.

Authors:  Yang Zhang; Pengyu Zhang; Aili He; Yun Yang; Jianli Wang; Hui Zhang; Wanggang Zhang
Journal:  Oncotarget       Date:  2017-06-13

3.  C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia.

Authors:  Bo Lei; Yinxia Chen; Aili He; Jing Luo; Pengyu Zhang; Fuling Zhou; Jie Liu; Xin Meng; Jing Wang; Wanggang Zhang
Journal:  Oncol Lett       Date:  2017-05-02       Impact factor: 2.967

4.  Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/β-catenin signaling pathway.

Authors:  Pengyu Zhang; Xuan Zhao; Wenjuan Zhang; Aili He; Bo Lei; Wanggang Zhang; Yinxia Chen
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.